Thailand Medical News - For All The Latest Breaking Medical News, Health News, Research News, COVID-19 News, Outbreak News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Heart And Cardiology News, Epigenetic News, Cancer News,

Nikhil Prasad  Fact checked by:Thailand Medical News Team Jan 30, 2024  3 weeks, 4 days, 15 hours, 21 minutes ago

COVID-19 News: Study Finds That SARS-CoV-2 Nsp3 Proteins Binds To Host Fragile X Mental Retardation Proteins FMR1 And FXR1-2!

facebook sharing button Share
twitter sharing button Tweet
linkedin sharing button Share
COVID-19 News: Study Finds That SARS-CoV-2 Nsp3 Proteins Binds To Host Fragile X Mental Retardation Proteins FMR1 And FXR1-2!
Nikhil Prasad  Fact checked by:Thailand Medical News Team Jan 30, 2024  3 weeks, 4 days, 15 hours, 21 minutes ago
COVID-19 News: The ongoing battle against the COVID-19 pandemic has prompted relentless efforts by researchers globally to unravel the mysteries of the SARS-CoV-2 virus. In a recent study covered in this COVID-19 News report, scientists from the University of Copenhagen in Denmark, the University of Texas Medical Branch in Galveston, USA, and the University of Umeå in Sweden have discovered a significant interaction between the SARS-CoV-2 nonstructural protein 3 (Nsp3) and fragile X mental retardation proteins (FMRPs), shedding light on the intricate molecular mechanisms underlying viral replication and host cell hijacking.

Interaction of FXR1 to UBAP2L.
(A) ITC measurements of a reported RNA binding to FXR1. Binding to FXR1 215–360 was monitored and as a control the SARS-CoV-2 N protein (n = 1). (B) Mass spectrometry analysis of the interactomes of affinity-purified YFP-tagged FXR1 WT and FXR1 I304N. Proteins specifically binding to FXR1 WT indicated in the volcano plot. Data from 4 technical repeats. (C) The indicated YFP-tagged FXR1 proteins were expressed and purified from HeLa cells and binding to UBAP2L determined by western blot. Representative of 2 biological replicates.

Thailand Medical News would like to add that SARS-CoV-2 Nsp3 proteins binding to host fragile X mental retardation proteins (FMRPs) could possibly lead to neurological and brain issues that warrants urgent detailed research.
Understanding the complex interplay between viruses and host factors is crucial for devising effective antiviral strategies and enhancing our ability to combat emerging infectious diseases. This study provides unprecedented insights into how the SARS-CoV-2 virus manipulates host cell proteins, particularly FMRPs, and explores the implications of this interaction on viral replication, stress granule formation, and potential connections to fragile X syndrome.
Stress Granules and Viral Interference
Viruses, with their limited set of proteins, heavily rely on exploiting host cellular machinery for efficient replication. One key target for viruses is the disruption of stress granules, large protein-RNA assemblies that play a central role in antiviral signaling. Stress granules form in response to various stress signals, including viral infections, and act as dynamic hubs for coordinating cellular responses. The study highlights the complexity of stress granule formation, involving over 250 host proteins, and underscores its significance in antiviral defense mechanisms.

Coronaviruses, including SARS-CoV-2, employ diverse strategies to disrupt stress granule formation and co-opt host factors to facilitate their replication. The nucleocapsid protein (N) and accessory open reading frames (ORFs) have previously been implicated in disrupting stress granules. The study reveals that the N protein of SARS-CoV-2 contains a specific motif that binds to G3BP1/2, disrupting stress granule formation. Moreover, the research unveils a novel facet, showcasing the interference of the SARS-CoV-2 Nsp3 protein with fragile X mental retardation proteins (FMRPs), unraveling a previously unknown layer of complexity in the virus-host interaction.
Discovery of the Nsp3-FMRP Interaction
The Nsp3 protein, the largest in the coronavirus family, presents a multifunctional challenge for researchers due to its size, transmembrane domains, and critical roles during infection. The study focused on deciphering the interaction between SARS-CoV-2 Nsp3 and FMRPs. Through meticulous experiments and analyses, the researchers identified a 20-amino acid region in the hypervariable region (HVR) of Nsp3 that binds directly to FMRPs, disrupting their interaction with the stress granule component UBAP2L.
Engineering mutant SARS-CoV-2 viruses that were incapable of binding FMRPs revealed a striking attenuation in viral replication in vitro. This highlights the significance of the Nsp3-FMRP interaction in supporting the virus's ability to replicate efficiently within host cells. The disruption of this interaction resulted in a delayed kinetic progression of viral pathogenesis in vivo, shedding light on the nuanced interplay between the virus and host during the early stages of infection.
Structural Insights into Nsp3-FMRP Binding
To gain a detailed understanding of the Nsp3-FMRP complex, the researchers conducted structural analyses and identified the key residues in the Nsp3 protein mediating the interaction with FMRPs. The study revealed that a specific peptide motif in Nsp3 binds directly to the two central KH domains of FMRPs. This interaction was disrupted by the I304N mutation found in a patient with fragile X syndrome, providing a potential molecular link between viral infection and the underlying defects in fragile X syndrome.
Moreover, the study elucidated that the Nsp3-FMRP interaction competes directly with UBAP2L for binding to FMRPs. This competition results in the displacement of stress granule components, particularly UBAP2L, and prevents the incorporation of FMRPs into stress granules. The findings unveil a mechanism by which SARS-CoV-2 disrupts host antiviral defenses, offering a molecular perspective on the potential impact of this interaction on viral pathogenesis.
Implications for COVID-19 and Fragile X Syndrome
The study's findings not only contribute to our understanding of SARS-CoV-2 biology but also offer potential insights into the molecular defects associated with fragile X syndrome. Fragile X syndrome, characterized by inherited mental retardation, has been linked to mutations in FMR1, the gene encoding FMRPs. The study suggests that disruptions in the Nsp3-FMRP interaction may impact stress granule formation and could be connected to the neurological manifestations observed in fragile X syndrome.
The researchers propose that the ability of Nsp3 to antagonize host antiviral mechanisms may involve its effect on stress granule composition and assembly. The intricate dance between SARS-CoV-2 and host cellular factors, particularly stress granules, presents a critical interface that influences the outcome of infection. The study advocates for further exploration of these interactions to develop targeted antiviral therapies and potentially inform live-attenuated vaccine approaches.
In conclusion, the study provides a comprehensive exploration of the intricate interactions between SARS-CoV-2 Nsp3 and host FMRPs, shedding light on the molecular mechanisms that govern viral replication and host cell manipulation. The discovery of a novel peptide motif in Nsp3 that disrupts stress granule formation by competing with UBAP2L for FMRP binding opens avenues for future research into antiviral strategies.
The impact of the Nsp3-FMRP interaction on viral pathogenesis, both in vitro and in vivo, underscores the complexity of the virus-host interplay and its implications for COVID-19. Additionally, the study offers potential connections between this viral interaction and the molecular defects associated with fragile X syndrome, highlighting the multifaceted nature of SARS-CoV-2's impact on human health.
As the global scientific community continues its tireless efforts to combat the COVID-19 pandemic, unraveling the intricate dance between SARS-CoV-2 and host cellular factors provides crucial insights that may pave the way for targeted therapeutic interventions and a deeper understanding of the virus's impact on human health.
The study findings were published in the peer-reviewed journal: EMBo Reports.
For the latest COVID-19 News, keep on logging to Thailand Medical News.


Jun 10, 2023  9 months ago
COVID-19 News - DNA Methylation - Asymptomatic SARS-CoV-2 Infections
Sep 08, 2022  1 year ago
Source- Medical News - COVID-19 Research - Impaired Pain Modulation
Aug 04, 2022  2 years ago
Source: Medical News - SARS-CoV-2 & Cancer
Aug 13, 2020  4 years ago
Source: Supplements For COVID-19